Global Diphtheria Toxoid Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Diphtheria Toxoid Market Insights, Forecast to 2034
Diphtheria toxoid is a biological product that is detoxified by diphtheria toxin plus formaldehyde at a certain temperature and becomes non-toxic while still maintaining immunogenicity. It is the most effective preparation to prevent diphtheria.
Market Analysis and InsightsGlobal Diphtheria Toxoid Market
Global Diphtheria Toxoid market is expected to reach to US$ 225 million in 2024, with a positive growth of %, compared with US$ 173 million in 2022. Backed with the increasing demand from downstream industries, Diphtheria Toxoid industry is evaluated to reach US$ 315.6 million in 2029. The CAGR will be 5.8% during 2024 to 2029.
Globally, Diphtheria Toxoid key companies include Biocompare, GSK, Zoetis, Sanofi and Merck, etc. Biocompare, GSK, Zoetis are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Diphtheria Toxoid were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Diphtheria Toxoid market and estimated to attract more attentions from industry insiders and investors.
Diphtheria Toxoid can be divided into Reducing Toxin and Denatured Toxin, etc. Reducing Toxin is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Diphtheria Toxoid is widely used in various fields, such as Hospitals, Clinics and Ambulatory Surgical Centers,, etc. Hospitals provides greatest supports to the Diphtheria Toxoid industry development. In 2022, global % revenue of Diphtheria Toxoid went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Diphtheria Toxoid market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Diphtheria Toxoid market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report

Biocompare
GSK
Zoetis
Sanofi
Merck
Segment by Type
Reducing Toxin
Denatured Toxin
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Diphtheria Toxoid introduction, etc. Diphtheria Toxoid Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Diphtheria Toxoid
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Diphtheria Toxoid Market
Global Diphtheria Toxoid market is expected to reach to US$ 225 million in 2024, with a positive growth of %, compared with US$ 173 million in 2022. Backed with the increasing demand from downstream industries, Diphtheria Toxoid industry is evaluated to reach US$ 315.6 million in 2029. The CAGR will be 5.8% during 2024 to 2029.
Globally, Diphtheria Toxoid key companies include Biocompare, GSK, Zoetis, Sanofi and Merck, etc. Biocompare, GSK, Zoetis are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Diphtheria Toxoid were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Diphtheria Toxoid market and estimated to attract more attentions from industry insiders and investors.
Diphtheria Toxoid can be divided into Reducing Toxin and Denatured Toxin, etc. Reducing Toxin is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Diphtheria Toxoid is widely used in various fields, such as Hospitals, Clinics and Ambulatory Surgical Centers,, etc. Hospitals provides greatest supports to the Diphtheria Toxoid industry development. In 2022, global % revenue of Diphtheria Toxoid went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Diphtheria Toxoid market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Diphtheria Toxoid market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report

By Company
Biocompare
GSK
Zoetis
Sanofi
Merck
Segment by Type
Reducing Toxin
Denatured Toxin
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Diphtheria Toxoid introduction, etc. Diphtheria Toxoid Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Diphtheria Toxoid
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
